Developmental Research Program (DRP)

发展研究计划（DRP）

• 批准号: 10024421
• 负责人: URSULA Anne MATULONIS
• 金额: $ 17.57万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-03 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10024421
• 关键词: Advocate; Attention; Award; Budgets; Cancer Center; Complement; Development; Diagnosis; Early Diagnosis; Ensure; Equilibrium; Evaluation; Faculty; Fostering; Funding; Goals; Grant; Institution; Malignant neoplasm of ovary; Mentors; Mentorship; Methods; Minority; Mission; Monitor; Pilot Projects; Prevention; Process; Productivity; Program Research Project Grants; Progress Reports; Request for Applications; Research; Research Activity; Research Personnel; Resistance; Resources; Specific qualifier value; TimeLine; Translational Research; Woman; base; community center; high risk; innovation; novel; programs; research and development; sound; success

PROJECT SUMMARY/ABSTRACT - DEVELOPMENTAL RESEARCH PROGRAM RESEARCH PLAN The overall goals of the Dana-Farber/Harvard Cancer Center (DF/HCC) Ovarian Cancer SPORE Developmental Research Program (DRP) are to support high risk/high potential pilot projects that take maximum advantage of new research opportunities within the DF/HCC Ovarian Cancer SPORE and to maintain this Program throughout the entire grant term. The selection and monitoring process will be led by the DRP Directors, Drs. Ursula Matulonis, Stephen Cannistra and Alan D’Andrea, with oversight from the other SPORE leader, Dr. Spriggs. The DF/HCC Ovarian Cancer DRP Executive Committee (EC) which is comprised on the DF/HCC SPORE committee, the External Advisory Board, the Internal Advisory Board (IAB) and the Ovarian Cancer Advocate Core of this Ovarian Cancer SPORE Project will directly participate in the review, scoring and selection of DRP Projects. The DRP will encourage applications from minorities and women as well as high risk/high payoff projects. Full access to DF/HCC Ovarian Cancer SPORE resources including Core access will be available to DRP Projects. Those projects that have demonstrated great progress and translational research potential will have the potential to become full SPORE Projects but only with the approval of the DF/HCC Ovarian Cancer DRP EC. Funding for the DRP is comprised partly from the Ovarian Cancer SPORE budget as well as significantly from DF/HCC institutions.

项目摘要/摘要 - 发展研究计划 研究计划 丹娜—法伯癌症研究所/哈佛大学癌症中心 (DF/HCC) 卵巢癌 SPORE 的总体目标 发展研究计划 (DRP) 将支持高风险/高潜力的试点项目 最大限度地利用 DF/HCC 卵巢癌 SPORE 中的新研究机会，并 在整个拨款期限内维持该计划。选择和监督过程将由 DRP 董事，博士。 Ursula Matulonis、Stephen Cannistra 和 Alan D’Andrea，在另一位的监督下 孢子领袖，斯普里格斯博士。 DF/HCC 卵巢癌 DRP 执行委员会 (EC) 由 DF/HCC SPORE 委员会、外部顾问委员会、内部顾问委员会 (IAB) 组成 该卵巢癌 SPORE 项目的卵巢癌倡导者核心将直接参与 DRP 项目的审查、评分和选择。 DRP 将鼓励少数族裔和 女性以及高风险/高回报项目。完全访问 DF/HCC 卵巢癌 SPORE 资源 包括核心访问权限将可供 DRP 项目使用。那些表现出色的项目 进展和转化研究潜力将有可能成为完整的 SPORE 项目，但仅 经 DF/HCC 卵巢癌 DRP EC 批准。 DRP 的资金部分来自 卵巢癌 SPORE 预算以及大量来自 DF/HCC 机构的预算。